Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aceragen, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aceragen, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Milano Vincent | Director | 8,987 | Aug 11, 2023 | 0 |
| Gowen Maxine | Director | 0Indirect | Aug 11, 2023 | 0 |
| Zein Youssef El | 10% Owner | 170,712Indirect | Jul 19, 2023 | 0 |
| Pillar Invest Corp | 10% Owner | 170,712Indirect | Jul 19, 2023 | 0 |
| Umari Abude | 10% Owner | 170,712Indirect | Jul 19, 2023 | 0 |
| Pillar Partners Foundation, L.P. | 10% Owner | 170,712Indirect | Jul 19, 2023 | 0 |
| Pillar Pharmaceuticals 6, L.P. | 10% Owner | 170,712Indirect | Jul 19, 2023 | 0 |
| Chopra Atul | 10% Owner | 1,205,158Indirect | May 18, 2023 | 0 |
| Jordan Andrew R | CHIEF STRATEGY OFFICER | 451,890 | Feb 2, 2023 | 0 |
| Kirby John J. | CHIEF FINANCIAL OFFICER | 316,893 | Feb 2, 2023 | 0 |
| Lim Bryant David | SVP AND GENERAL COUNSEL | 309,695 | Feb 2, 2023 | 0 |
| Salain Daniel | CHIEF OPERATING OFFICER | 1,469,482 | Feb 2, 2023 | 0 |
| Kraus Carl N | CHIEF MEDICAL OFFICER | – | Feb 2, 2023 | 0 |
| Taylor John Clayton | CHIEF EXECUTIVE OFFICER | 1,469,482 | Feb 2, 2023 | 0 |
| Wooten Ronald J | Director | 5Indirect | Jan 19, 2023 | 0 |
| NQ POF V GP, Ltd. | Director, Other: See Remarks | 5 | Jan 18, 2023 | 0 |
| NovaQuest Co-Investment Fund XV, L.P. | Director, Other: See Remarks | 5 | Jan 18, 2023 | 0 |
| Dougherty Michael R | Director | 375,155 | Jan 12, 2023 | 0 |
| Soland Daniel B | CHIEF OPERATING OFFICER | – | Jul 7, 2022 | 0 |
| Geraghty James A | Director | – | Jun 27, 2022 | 0 |
| Schafer Carol | Director | – | Jun 27, 2022 | 0 |
| Csimma Cristina | Director | – | Jun 27, 2022 | 0 |
| Goldberg Mark Alan | Director | – | Jun 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 (view filing) | Dec 17 | 4 days | Kirby John J.CHIEF FINANCIAL OFFICER | PPurchase | +10.0K | $0.62 | +$6.20K | +36.2%37.6K after | |
| May 18, 2023 (view filing) | May 11 | 7 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −47.2K | $1.84 | −$86.9K | −3.2%1.42M after | 20 lots |
| May 18, 2023 (view filing) | May 12 | 6 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −81.5K | $1.56 | −$126.9K | −5.7%1.34M after | 21 lots |
| May 18, 2023 (view filing) | May 15-17 | 3 daysLate | Chopra Atul10% Owner | SSaleCommon Stock, $0.001 per share | −135.7K | $1.44 | −$195.4K | −10.1%1.21M after | 25 lots |
| Jul 19, 2023 (view filing)4:05 PM ET | Jul 12-13 | 7 daysLate | Zein Youssef El and 4 others10% Owner | SSale | −5.82K | $1.56 | −$9.10K | −3.4%164.9K after | 2 lots |
| Jul 19, 2023 (view filing)4:05 PM ET | May 17 | 63 daysLate | Zein Youssef El and 4 others10% Owner | PPurchase | +27.0K | $1.42 | +$38.3K | +18.8%170.7K after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Milano VincentDirector | SSale | −3.28K | $0.53 | −$1.74K | −26.8%8.99K after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Gowen MaxineDirector | SSale | −51 | $0.51 | −$26.01 | −100.0%0 after |